Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P05107: Variant p.Gly169Arg

Integrin beta-2
Gene: ITGB2
Feedback?
Variant information Variant position: help 169 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 169 (G169R, p.Gly169Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In LAD1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 169 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 769 The length of the canonical sequence.
Location on the sequence: help LGGDLLRALNEITESGRIGF G SFVDKTVLPFVNTHPDKLRN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPDKLRN

Mouse                         LGGDLLQALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRN

Pig                           LGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRN

Bovine                        LGGDLLRALNGITESGRIGFGSFVDKTVLPFVNTHPEKLRN

Goat                          LGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRN

Sheep                         LGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 23 – 769 Integrin beta-2
Topological domain 23 – 700 Extracellular
Domain 124 – 363 VWFA
Binding site 173 – 173 in LIMBS binding site
Disulfide bond 33 – 447
Beta strand 165 – 171



Literature citations
Distinct mutations in two patients with leukocyte adhesion deficiency and their functional correlates.
Wardlaw A.J.; Hibbs M.L.; Stacker S.A.; Springer T.A.;
J. Exp. Med. 172:335-345(1990)
Cited for: VARIANTS LAD1 PRO-149 AND ARG-169; Molecular basis for a severe case of leukocyte adhesion deficiency.
Corbi A.; Vara A.; Ursa A.; Rodriguez M.C.G.; Fontan G.; Sanchez-Madrid F.;
Eur. J. Immunol. 22:1877-1881(1992)
Cited for: VARIANT LAD1 ARG-169;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.